CD Genomics

Global RNA Analysis Market Report 2022: Single Cell Transcriptomics And Associated Big Data Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Monday, November 7, 2022
Biotechnology, Genetics, Health, MicroRNA, RNA, Research, PCR, NGS, CD Genomics, Investment, Element, RNA transfection, Biotechnology, CAGR, Industry, Asia-Pacific, Biomarker, Application, Digital, Data management, COVID-19, Clifton Springs Hospital & Clinic, Cros, Transcriptomics technologies, Transcriptome, USFDA, USD, Drug development, Sequencing, Kits, Real-time, Union, Genomics, Gene, Patient, Hospital, Fine chemical, Pharmaceutical industry, Technology, Instrument

The global RNA analysis market size is anticipated to reach USD 42.30 billion by 2030, expanding at a CAGR of 16.59% from 2022 to 2030.

Key Points: 
  • The global RNA analysis market size is anticipated to reach USD 42.30 billion by 2030, expanding at a CAGR of 16.59% from 2022 to 2030.
  • Technological advancements in this industry can be attributed to the increasing applications of transcriptome sequencing in life science for capturing polyadenylated RNA.
  • With the expansion of next-generation high-throughput sequencing technology, the analysis of transcriptomes has been gradually improving the understanding of the regulatory network of RNA-based genes.
  • For instance, in July 2021, the Lithuanian team is developing a droplet-based technique for simultaneous mRNA and microRNA capture and sequencing in a single cell.

Global Bioinformatics Services Market Research Report to 2027 - Increasing Focus on Outsourcing for the Management of Large Volumes of Data Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Monday, May 23, 2022
Health, Biotechnology, QIAGEN, PerkinElmer, Use, R, Certification, Customer support, Investment, News, Collaborative partnership, Agilent Technologies, Business Growth Fund, Eurofins Scientific, Strategic management, USD, Decision-making, COVID-19, Mergers and acquisitions, CD Genomics, Genomics, Illumina, Inc., BGI Group, Thermo Fisher Scientific, Market share analysis, CAGR, Acquisition, Growth, Value, Retail, Fine chemical

What are the inhibiting factors and impact of COVID-19 shaping the Global Bioinformatics Services Market during the forecast period?

Key Points: 
  • What are the inhibiting factors and impact of COVID-19 shaping the Global Bioinformatics Services Market during the forecast period?
  • Which are the products/segments/applications/areas to invest in over the forecast period in the Global Bioinformatics Services Market?
  • What is the market share of the leading vendors in the Global Bioinformatics Services Market?
  • What modes and strategic moves are considered suitable for entering the Global Bioinformatics Services Market?

Global RNA Analysis Market Research Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 21, 2021
Biotechnology, Genetics, Health, Death, Agilent Technologies, Genomics, PCR, Genome, Gene, Industry, MicroRNA, Life Technologies Corp. v. Promega Corp., Enzyme, Illumina, Inc., RNA interference, Real-time polymerase chain reaction, Drug discovery, Transcriptome, Merck, Bio-Rad Laboratories, Eurofins Scientific, RNA, Thermo Fisher Scientific, Roche, RT, Merck Group, Mindful Scientific Inc., Forensic pathology, Danaher, Collection, Protein, Company, Danaher Corporation, COVID-19, Ribonuclease, Qiagen, Polymerase chain reaction, CD Genomics, DNA, Vaccine, 3D printing

The "Global RNA Analysis Market 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global RNA Analysis Market 2021-2026" report has been added to ResearchAndMarkets.com's offering.
  • RNA species (messenger RNA, transfer RNA, and ribosomal RNA) play an important role in the translation of genetic information from DNA to proteins.
  • This report explores the present and future market values of the RNA analysis market, particularly by type of analysis such as microarrays, polymerase chain reaction (PCR), sequencing technologies, and RNAi gene silencing.
  • Also included in the report is a discussion of the impact of COVID-19 on the market and profiles of leading companies in the RNA analysis market.

Benson Hill, RAPiD Genomics to Collaborate on Crop Improvement

Retrieved on: 
Thursday, May 16, 2019
Branches of biology, Biology, Life sciences, Molecular biology, DNA, Biotechnology, Genetics, Genotyping, DNA sequencing, Genomics, Sequencing, CD Genomics

"RAPiD Genomics has the technology to accelerate genotyping using next-generation sequencing," said Mike Thompson , Vice President, Partner Development at Benson Hill, which is based in St. Louis.

Key Points: 
  • "RAPiD Genomics has the technology to accelerate genotyping using next-generation sequencing," said Mike Thompson , Vice President, Partner Development at Benson Hill, which is based in St. Louis.
  • "Under this agreement, we'll be able to go to RAPiD Genomics for sequencing and genotyping that our customers can't do themselves.
  • Benson Hill empowers innovators with a revolutionary crop design platform to develop healthier and more sustainable food and ingredients.
  • RAPiD Genomics offers genotyping, genomics and data analysis services utilizing next-generation sequencing and computational biology.